This is a review about cyclin D1, based on 113 published articles (read how Labome selects the articles), using cyclin D1 antibody in all methods. It is aimed to help Labome visitors find the most suited cyclin D1 antibody.
cyclin D1 synonym: BCL1; D11S287E; PRAD1; U21B31; B-cell CLL/lymphoma 1; B-cell lymphoma 1 protein; BCL-1 oncogene; G1/S-specific cyclin-D1; PRAD1 oncogene

gallery
Santa Cruz BiotechnologySanta Cruz Biotechnology cyclin D1 product
  • immunocytochemistryVidya Mamidipudi et al. applied Santa Cruz Biotechnology cyclin D1 antibody to detect cyclin D1 in NIH 3T3 cells transiently transfected with vector, RACK1, or mutant RACK1 [ncbi , more ] in 2004 and Christina R Kahl et al. used Santa Cruz Biotechnology cyclin D1 antibody to detect cyclin D in human WI-38 fibroblasts [ncbi , more ]. In 2002, Irene H L Hamelers et al. employed Santa Cruz Biotechnology cyclin D1 antibody to study the mechanism by which IGF-I induces the activation of the cyclin D1-CDK4 complex [ncbi , more ].
  • immunohistochemistryIn 2005, Hong Bing Ma et al. applied Santa Cruz Biotechnology cyclin D1 antibody to study cyclin D1, p16, and retinoblastoma protein expressions in gallbladder carcinoma [ncbi , more ]. In 2003, N J Trudgill et al. utilized Santa Cruz Biotechnology cyclin D1 antibody to study the cell cycle regulation in patients with IM at the GOJ [ncbi , more ]. In 2002, Luis M Schang et al. used Santa Cruz Biotechnology cyclin D1 antibody to study the effect of expression of nuclear cdk2 and cdk4 in neurons on reactivation of herpes simplex virus [ncbi , more ]. In 2001, K Kurose et al. employed Santa Cruz Biotechnology cyclin D1 antibody to study the correlation between PTEN and Akt, p27, cyclin D1 in primary epithelial ovarian carcinomas [ncbi , more ].
  • immunoprecipitationIn 2005, Nikos Tapinos et al. utilized Santa Cruz Biotechnology cyclin D1 antibody to investigate the activation of Erk1/2 by intracellular M. leprae [ncbi , more ]. In 2002, Cynthia C Sprenger et al. utilized Santa Cruz Biotechnology cyclin D1 antibody to study the effects of over-expression of the potential tumor suppressor gene IGFBP-rP1/mac25 on cell-cycle kinetics in human prostate cancer cells [ncbi , more ].
  • western blotIn 2013, Uma Karthika Rajarajacholan et al. employed Santa Cruz Biotechnology cyclin D1 antibody to perform western blot in order to study how ING1a induces senescence [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was employed in 2010 to investigate the role of c-Abl tyrosine kinase in the regulation of cardiac growth and development [ncbi , more ], to investigate the role of ILK in the regulation of human intestinal cells migration and proliferation [ncbi , more ]and to perform western blot in order to clarify that Skp2 involved in the p19Arf-p53 pathway independent cellular senescence [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was utilized in 2009 to investigate the role of BRAF in the regulation of RAF-MEK signaling pathway [ncbi , more ], to study the role for prostate specific membrane antigen in regulating the expression of IL-6 and CCL5 in prostate tumour cells [ncbi , more ], to study the mechanism underlying PKCalpha suppressing tumor in the intestine (catalog: sc-753,sc-450) [ncbi , more ], to investigate the role of Aurora B in the regulation of postmitotic endoreduplication checkpoint [ncbi , more ], to perform western blot in order to study the roles of S100B protein during the astrocyte shape and migration [ncbi , more ], to perform western blot in order to study the regulation of NANOG in G1 to S transition in human embryonic stem cells [ncbi , more ], to perform western blot in order to study the role of snail1-mediated suppression of CYLD in melanoma malignancy [ncbi , more ], to detect cyclin D1 in western blot in order to find out the novel mechanism by which eIF4E levels are regulated at the level of mRNA stability [ncbi , more ], to perform western blot in order to show the role of CK2B in apoptosis resistance and cell proliferation in endometrial carcinoma [ncbi , more ], to carry out western blot analysis in order to investigate whether FGFR4 plays a role in promoting the progression of hepatocellular carcinoma [ncbi , more ]and to study the role of tuberin and OGG1 in the pathogenesis of angiomyolipoma in TSC patients [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was applied in 2008 to study the role of Vsx2 in mediating mitogen signaling [ncbi , more ], to study molecular mechanisms underlying TSH-secreting pituitary tumors (TSHomas) (catalog: sc-450) [ncbi , more ], to detect cyclin D1 expression in human WI-38 cells and lung carcinoma cell line A549 [ncbi , more ]and to examine the effects of combining a proteasome inhibitor with an HDAC inhibitor in GBM cell lines [ncbi , more ]. In 2007, Yulan Liu et al. used Santa Cruz Biotechnology cyclin D1 antibody to perform western blot in order to show the mechanism of cancer cell proliferation and invasion inhibition by PCDGF/GEP blockade [ncbi , more , fig ]. In 2006, Irina Groisman et al. employed Santa Cruz Biotechnology cyclin D1 antibody to study the role of CPEB in cellular senescence [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was employed in 2005 to investigate the repression of RNA polymerase I transcription by PTEN [ncbi , more ], to investigate the activation of Erk1/2 by intracellular M. leprae [ncbi , more ], to study the role of Dmp1 in Ras-Raf-Arf signaling [ncbi , more ], to study the role of an unliganded TRbeta mutant in pituitary tumorigenesis in vivo (catalog: sc-450) [ncbi , more ]and to investigate the regulation of Cdc6 protein stability by p53 [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was applied in 2004 to detect cyclin D in human WI-38 fibroblasts [ncbi , more ], to study HFz6 represses the canonical Wnt pathway by transmitting an antagonistic signaling cascade [ncbi , more ], to study the role of the Pak1 pathway in the expression of cyclin D1 [ncbi , more ]and to detect cyclin D1 in NIH 3T3 cells transiently transfected with vector, RACK1, or mutant RACK1 [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was applied in 2003 to study the dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells [ncbi , more ], to facilitate the establishment of an in vitro model that can be reliably used to study the pathogenesis of MCL [ncbi , more ], to study the association of p55 with Rb [ncbi , more ]and to study the role of AMF/PGI in the regulation of cell proliferation [ncbi , more ]. Santa Cruz Biotechnology cyclin D1 antibody was utilized in 2002 to study the aberrant localization of catenin correlated with overexpression of its target gene in human papillary thyroid cancer [ncbi , more ], to study the inhibition of ERK phosphorylation by UVB [ncbi , more ], to identify the BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling by a senescence rescue screen [ncbi , more ], to study the effects of SF/HGF, c-myc, p27, Cdk2, or E2F1 on glioblastoma cell cycle progression [ncbi , more ], to study the effects of over-expression of the potential tumor suppressor gene IGFBP-rP1/mac25 on cell-cycle kinetics in human prostate cancer cells [ncbi , more ], to examine cyclin D1 levels in human HT29 colon carcinoma sublines U9, HP1, HD3 and HD4 [ncbi , more ], to study the effects of black tea polyphenols on IGF-I signal transduction pathways in normal prostate epithelial cells and Du145 prostate carcinoma cells [ncbi , more ], to stduy the mechanism (s) by which Cdk4 activity is regulated in MCF-7 cells [ncbi , more ]and to study the RB activation defect in tumor cell lines [ncbi , more ]. M S Neshat et al. employed Santa Cruz Biotechnology cyclin D1 antibody to demonstrate that PTEN-deficient cancer cells are more sensitive to pharmacologic inhibition of FRAP/mTOR [ncbi , more ] in 2001 and R A Campbell et al. used Santa Cruz Biotechnology cyclin D1 antibody to study activation of ER by the PI 3-kinase/AKT survival pathways [ncbi , more ].
EMD MilliporeEMD Millipore cyclin D1 product
  • immunocytochemistryIn 2007, Nektarios Barabutis et al. applied EMD Millipore cyclin D1 antibody to study the stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor [ncbi , more ].
  • immunohistochemistryIn 2006, Maryline Paris et al. applied EMD Millipore cyclin D1 antibody to demonstrate the homeodomain transcription factor Phox2a coordinates cell cycle exit and differentiation by inducing p27 (Kip1) transcription [ncbi , more ].
  • immunoprecipitationIn 2002, Irene H L Hamelers et al. employed EMD Millipore cyclin D1 antibody to study the mechanism by which IGF-I induces the activation of the cyclin D1-CDK4 complex [ncbi , more ].
  • western blotIn 2010, Yuping Luo et al. used EMD Millipore cyclin D1 antibody to perform western blot in order to study the roles of the fragile X mental retardation protein during the regulations of the proliferation and differentiation of adult neural stem/progenitor cells [ncbi , more ]. In 2009, Janice B B Lam et al. applied EMD Millipore cyclin D1 antibody to show that adiponectin haploinsufficiency can promote mammary tumorigenesis through inhibition of PTEN activity and activation of PI3K/Akt signalling pathway [ncbi , more ]. Melanie Konigshoff et al. employed EMD Millipore cyclin D1 antibody to quantify and localize the expression and activity of the Wnt/beta-catenin pathway in IPF (catalog: 06-137) [ncbi , more ] in 2008 and Emily J Faivre et al. used EMD Millipore cyclin D1 antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ]. In 2007, Jörg Weiske et al. utilized EMD Millipore cyclin D1 antibody to study the role of the tumor suppressor Fhit in the regulation of beta-catenin-mediated gene transcription in human cancer cells [ncbi , more ]. In 2006, Dan Lu et al. utilized EMD Millipore cyclin D1 antibody to study the roles of ATF3 in both cell death and cell cycle regulation [ncbi , more ]. Raju R Raval et al. used EMD Millipore cyclin D1 antibody to study the differing effect of HIF1 and HIF2 in von Hippel-Lindau-Associated renal cell carcinoma [ncbi , more ] in 2005 and Bing Zhu et al. used EMD Millipore cyclin D1 antibody to study the suppression of cyclic GMP-specific phosphodiesterase 5 promoting apoptosis and inhibiting growth in HT29 cells [ncbi , more ]. In 2004, Lea Madi et al. applied EMD Millipore cyclin D1 antibody to compare the expression of A3 adenosine receptor in tumor versus normal cells [ncbi , more ]. In 2001, B A Schmidt et al. utilized EMD Millipore cyclin D1 antibody to detect cyclin D1 in the patients' tumor and adjacent normal testicular tissue [ncbi , more ].
Cell Signaling TechnologyCell Signaling Technology cyclin D1 product
  • immunoprecipitationIn 2007, Liuqing Yang et al. employed Cell Signaling Technology cyclin D1 antibody to study the role of p68 RNA helicase in platelet-derived growth factor-induced cell proliferation [ncbi , more ].
  • western blotIn 2010, Kar Lok Kong et al. employed Cell Signaling Technology cyclin D1 antibody to investigate the function of UPK1A in esophageal squamous cell carcinoma [ncbi , more ]. Vinicio A de Jesus Perez et al. applied Cell Signaling Technology cyclin D1 antibody to study the role for bone morphogenetic protein 2 in inducing pulmonary angiogenesis and its mechanism [ncbi , more ] in 2009 and Ozgur Sahin et al. used Cell Signaling Technology cyclin D1 antibody to combine computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancer [ncbi , more ]. In 2008, David Yu Greenblatt et al. utilized Cell Signaling Technology cyclin D1 antibody to perform western blot in order to study the effects of valproic acid in medullary thyroid cancer cells [ncbi , more ]. Liuqing Yang et al. employed Cell Signaling Technology cyclin D1 antibody to study the role of p68 RNA helicase in platelet-derived growth factor-induced cell proliferation [ncbi , more ] in 2007 and Neeraj K Saxena et al. used Cell Signaling Technology cyclin D1 antibody to study the recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3 by leptin and its stimulation of breast cancer cells [ncbi , more ]. In 2006, Ping Zhang et al. used Cell Signaling Technology cyclin D1 antibody to perform western blot in order to find out the genes involved with cisplatin resistance in human oral squamous cell carcinoma cell line [ncbi , more ]. Cell Signaling Technology cyclin D1 antibody was applied in 2005 to detect Cyclin D1 in HT-29 cells treated with NMT1-1 siRNA or NMT2-4 siRNA [ncbi , more ], to study the inhibition of nuclear import of LIMK2 in endothelial cells [ncbi , more ], to study retinoblastoma phosphorylation in neuronal cell death [ncbi , more ]and to study that tumor suppressor SMAR1 mediates Cyclin D1 repression by recruitment of the SIN3/Histone deacetylase 1 complex [ncbi , more ]. In 2004, Sung Kwon Moon et al. utilized Cell Signaling Technology cyclin D1 antibody to study that disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation cyclin D1 product
  • immunohistochemistryIn 2002, Katsu Ishigaki et al. utilized Life Technologies Corporation cyclin D1 antibody to study the aberrant localization of catenin correlated with overexpression of its target gene in human papillary thyroid cancer [ncbi , more ].
  • western blotIn 2008, Anjia Han et al. employed Life Technologies Corporation cyclin D1 antibody to demonstrate that sulindac suppresses beta-catenin expression in human cancer cells [ncbi , more ].
Thermo Scientific Pierce ProductsThermo Scientific Pierce Products cyclin D1 product
  • block or activateIn 2002, Cristina Broceño et al. employed Thermo Scientific Pierce Products cyclin D1 antibody to study the CDK Activition in tumor cell lines [ncbi , more ].
  • immunohistochemistryHyoung gon Lee et al. employed Thermo Scientific Pierce Products cyclin D1 antibody to carry out immunohistochemistry assays in order to investigate the functional role of Myc in mediating hypertrophic cardiomyopathy and heart failure [ncbi , more ] in 2009 and Dong Chen et al. used Thermo Scientific Pierce Products cyclin D1 antibody to perform immunohistochemistry in order to study the features of the potential molecular oncogenic mechanism of CDK6-BLPDs [ncbi , more ]. In 2003, Lin Wang et al. utilized Thermo Scientific Pierce Products cyclin D1 antibody to study the relationship of ARHI expression to the progression of breast cancer [ncbi , more ].
  • immunoprecipitationIn 2006, Laurence Bockstaele et al. utilized Thermo Scientific Pierce Products cyclin D1 antibody to study the role for cyclins and CDK "inhibitors" in Thr172 phosphorylation of CDK4 [ncbi , more ]. In 2002, Sandra Ciarallo et al. applied Thermo Scientific Pierce Products cyclin D1 antibody to study the different p27Kip1 phosphorylation patterns during cell cycle progression in human epithelial cells resistant to transforming growth factor beta-mediated G1 arrest [ncbi , more ].
  • western blotIn 2010, Romaine I Fernando et al. employed Thermo Scientific Pierce Products cyclin D1 antibody to carry out western blot analysis in order to investigate the role of the T-box transcription factor Brachyury in tumor cells epithelial-mesenchymal transition and and tumor progression [ncbi , more ]. Thermo Scientific Pierce Products cyclin D1 antibody was utilized in 2009 to demonstrate that Cold-Inducible RNA-Binding Protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation [ncbi , more ], to show that Hsp90 co-chaperone CDC37 can maintain the oncogenic protein kinase clients [ncbi , more ]and to study the mechanism underlying PKCalpha suppressing tumor in the intestine [ncbi , more ]. In 2007, Daniel Lechner et al. applied Thermo Scientific Pierce Products cyclin D1 antibody to investigate basal and Vitamin D-regulated expression and activity of the synthesizing (CYP27B1) and metabolizing (CYP24A1) hydroxylase [ncbi , more ]. Thermo Scientific Pierce Products cyclin D1 antibody was applied in 2006 to study the role for parafibromin in parathyroid adenomas in protein from human tumor tissue and cells [ncbi , more ], to study the relation between overexpression of ribosomal protein L15 and cell proliferation in gastric cancer [ncbi , more ]and to study the role for cyclins and CDK "inhibitors" in Thr172 phosphorylation of CDK4 [ncbi , more ]. Thermo Scientific Pierce Products cyclin D1 antibody was used in 2005 to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10 [ncbi , more ], to study COLO-357 cell growth inhibition by TGF beta1 [ncbi , more ], to study that IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells [ncbi , more ]and to study the differing effect of HIF1 and HIF2 in von Hippel-Lindau-Associated renal cell carcinoma [ncbi , more ]. In 2003, Chris Albanese et al. used Thermo Scientific Pierce Products cyclin D1 antibody to study the role of IKK alpha on mitogenic signaling [ncbi , more ]. In 2001, A Schulze et al. utilized Thermo Scientific Pierce Products cyclin D1 antibody to study the transcriptional program induced by Raf in epithelial cells [ncbi , more ].
Rockland Immunochemicals, Inc.
  • western blotIn 2002, Heidi L Kenerson et al. utilized Rockland Immunochemicals, Inc. cyclin D1 antibody to study the expression of cyclin D1 in the Eker renal tumors [ncbi , more ].
BD Biosciences
  • immunohistochemistryIn 2007, Lanying Song et al. utilized BD Biosciences cyclin D1 antibody to study the role of Alk3 during AV cushion morphogenesis in mouse embryonic hearts [ncbi , more ].
  • western blotIn 2010, Veronique Marsaud et al. employed BD Biosciences cyclin D1 antibody to perform western blot in order to show the role of cyclin K and cyclin D1b in multiple myeloma [ncbi , more ]. In 2009, Ivan Topisirovic et al. applied BD Biosciences cyclin D1 antibody to detect cyclin D1 in western blot in order to find out the novel mechanism by which eIF4E levels are regulated at the level of mRNA stability [ncbi , more ]. In 2004, Chitkala Satyanarayana et al. employed BD Biosciences cyclin D1 antibody to study the effect of DRF 3188 on the cell cycle of MCF 7 breast cancer cells [ncbi , more ]. In 2003, Roberto R Rosato et al. utilized BD Biosciences cyclin D1 antibody to detect cyclin D1 in U937 cells incubated for 24 h with 1-mM SB or 2- M SAHA 100-ng/ml TRAIL in the absence or presence of the pan-caspase inhibitor BOC-D-fmk [ncbi , more ]. In 2001, Y Takasaki et al. applied BD Biosciences cyclin D1 antibody to study the PCNA multiprotein complexes [ncbi , more ].
Sigma-AldrichSigma-Aldrich cyclin D1 product
  • western blotIn 2008, Satoshi Yamakawa et al. applied Sigma-Aldrich cyclin D1 antibody to examine the effect of disulfide 1 on the cell cycle phases by the change of cyclin D1 expression [ncbi , more ]. In 2007, Agoston T Agoston et al. applied Sigma-Aldrich cyclin D1 antibody to study the effect of retinoblastoma pathway dysregulation on DNA methyltransferase 1 overexpression in cancer [ncbi , more ]. R G Hardy et al. employed Sigma-Aldrich cyclin D1 antibody to study the role of P-cadherin in colonic polyp formation [ncbi , more ] in 2002 and Tadashi Yoshii et al. used Sigma-Aldrich cyclin D1 antibody to study the requirement of galectin-3 phosphorylation for its anti-apoptotic function and cell cycle Aarrest [ncbi , more ].
DakoDako cyclin D1 product
  • immunohistochemistryIn 2009, Judit Pallares et al. used Dako cyclin D1 antibody to perform immunohistochemistry in order to show the role of CK2B in apoptosis resistance and cell proliferation in endometrial carcinoma [ncbi , more ]. In 2007, Paul M Weinberger et al. used Dako cyclin D1 antibody to study the localization of galectin-3 in benign and malignant thyroid neoplasms and to correlate this with alterations in beta-catenin and cyclin D1 expression in paraffin sections from human [ncbi , more ].
MBL International
  • western blotIn 2006, Mariko Tomita et al. employed MBL International cyclin D1 antibody to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells [ncbi , more ].
TSIEH SUN
  • immunohistochemistryIn 2003, Tsieh Sun et al. utilized cyclin D1 antibody to study the fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma [ncbi , more ].
Progen
  • immunohistochemistryIn 2003, Marco Chilosi et al. utilized Progen cyclin D1 antibody to study the role for aberrant Wnt/ catenin pathway activation in idiopathic pulmonary fibrosis [ncbi , more ].
Biocare Medical
  • immunohistochemistryIan Pitha-Rowe et al. used Biocare Medical cyclin D1 antibody to study the role of UBE1L in lung cancer chemoprevention [ncbi , more ] in 2004 and Daniel G Rosen et al. used Biocare Medical cyclin D1 antibody to study the role of persistence of ARHI expression in epithelial ovarian cancers [ncbi , more ].
UBI
  • immunocytochemistryIn 2004, Christina R Kahl et al. utilized UBI cyclin D1 antibody to detect cyclin D in human WI-38 fibroblasts [ncbi , more ].
  • western blotIn 2004, Christina R Kahl et al. utilized UBI cyclin D1 antibody to detect cyclin D in human WI-38 fibroblasts [ncbi , more ].
Leica Microsystems
  • immunohistochemistryIn 2008, Yasuhiro Okumura et al. employed Leica Microsystems cyclin D1 antibody to identify biomarkers in ductal carcinoma in situ of the breast with microinvasion in paraffin sections from human tumor [ncbi , more ]. In 2004, Takashi Suzuki et al. employed Leica Microsystems cyclin D1 antibody to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor [ncbi , more ]. In 2002, Yali Zhai et al. used Leica Microsystems cyclin D1 antibody to study the role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas [ncbi , more ].
  • immunoprecipitationIn 2004, Andrea G Lania et al. used Leica Microsystems cyclin D1 antibody to study its expression in proliferating transformed somatotroph cells [ncbi , more ].
  • western blotIn 2012, Maria Kalyuga et al. employed Leica Microsystems cyclin D1 antibody to perform western blot in order to study the estrogen sensitivity and the acquisition of antiestrogen resistance in luminal breast cancer [ncbi , more ]. In 2009, C Elizabeth Caldon et al. used Leica Microsystems cyclin D1 antibody to show that cyclin D1 is essential for estrogen regulation of cyclin E2 [ncbi , more ].
Figure
Santa Cruz monoclonal mouse anti-cyclin D1 was used in 1:500 dilution to perform western blot in order to show the mechanism of cancer cell proliferation and invasion inhibition by PCDGF/GEP blockade .
cyclin D1 antibody western blot Santa Cruz Biotechnology
cyclin D1 and CDK4 decreased after antisense PCDGF construct transfection in SW626 cells, which paralleled with the proliferation and invasion capability.
Yulan Liu et al. (2007). "Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2".PMID 17261172
Articles Reviewed
  1. Uma Karthika Rajarajacholan et al. (2013). "The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway".PMID 23472054
  2. Maria Kalyuga et al. (2012). "ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer".PMID 23300383
  3. Kar Lok Kong et al. (2010). "Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma".PMID 20978196
  4. Veronique Marsaud et al. (2010). "Cyclin K and cyclin D1b are oncogenic in myeloma cells".PMID 20459741
  5. Yuping Luo et al. (2010). "Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells".PMID 20386739
  6. Hui Kuan Lin et al. (2010). "Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence".PMID 20237562
  7. Zhaozhu Qiu et al. (2010). "c-Abl tyrosine kinase regulates cardiac growth and development".PMID 20080568
  8. Romaine I Fernando et al. (2010). "The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells".PMID 20071775
  9. David Gagné et al. (2010). "Integrin-linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin-dependent mechanism".PMID 19885839
  10. Hyoung gon Lee et al. (2009). "Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure".PMID 19779629
  11. C Elizabeth Caldon et al. (2009). "Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc".PMID 19564413
  12. Janice B B Lam et al. (2009). "Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities".PMID 19319191
  13. Samy L Habib et al. (2009). "Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients".PMID 19265534
  14. Christine A Pratilas et al. (2009). "(V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway".PMID 19251651
  15. Marco Colombatti et al. (2009). "The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways".PMID 19242540
  16. Marybeth A Pysz et al. (2009). "PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1".PMID 19232344
  17. Jayasree S Nair et al. (2009). "Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780".PMID 19225156
  18. Ana Artero-Castro et al. (2009). "Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation".PMID 19158277
  19. Flora Brozzi et al. (2009). "S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH".PMID 19147496
  20. Dong Chen et al. (2009). "Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders".PMID 19145199
  21. Vinicio A de Jesus Perez et al. (2009). "Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways".PMID 19139264
  22. Xin Zhang et al. (2009). "A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A".PMID 19139263
  23. Ramin Massoumi et al. (2009). "Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma".PMID 19124656
  24. Ozgur Sahin et al. (2009). "Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance".PMID 19118495
  25. Ivan Topisirovic et al. (2009). "Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer".PMID 19114552
  26. Judit Pallares et al. (2009). "CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation".PMID 19056846
  27. Xinqiang Huang et al. (2009). "Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis".PMID 19009564
  28. J R Smith et al. (2009). "Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors".PMID 18931700
  29. Yasuhiro Okumura et al. (2008). "Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion".PMID 18837981
  30. David Yu Greenblatt et al. (2008). "Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells".PMID 18520232
  31. Melanie Konigshoff et al. (2008). "Functional Wnt signaling is increased in idiopathic pulmonary fibrosis".PMID 18478089
  32. Satoshi Yamakawa et al. (2008). "Growth inhibition of human colon cancer cell line HCT116 by bis[2-(acylamino)phenyl] disulfide and its action mechanism".PMID 18451518
  33. Chunrong Yu et al. (2008). "Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells".PMID 18445700
  34. Crystal L Sigulinsky et al. (2008). "Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina".PMID 18417110
  35. Changxue Lu et al. (2008). "Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors".PMID 18356276
  36. Anjia Han et al. (2008). "Sulindac suppresses beta-catenin expression in human cancer cells".PMID 18291362
  37. Xinyu Zheng et al. (2008). "Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication".PMID 18234796
  38. Emily J Faivre et al. (2008). "Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors".PMID 18202149
  39. Jörg Weiske et al. (2007). "The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity".PMID 18077326
  40. Paul M Weinberger et al. (2007). "Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma".PMID 17515507
  41. Agoston T Agoston et al. (2007). "Retinoblastoma pathway dysregulation causes DNA methyltransferase 1 overexpression in cancer via MAD2-mediated inhibition of the anaphase-promoting complex".PMID 17456764
  42. Liuqing Yang et al. (2007). "Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression".PMID 17412694
  43. Nektarios Barabutis et al. (2007). "Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor".PMID 17372203
  44. Neeraj K Saxena et al. (2007). "leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3".PMID 17344214
  45. Yulan Liu et al. (2007). "Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2".PMID 17261172
  46. Daniel Lechner et al. (2007). "1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells".PMID 17029768
  47. Irina Groisman et al. (2006). "Control of cellular senescence by CPEB".PMID 17015432
  48. Maryline Paris et al. (2006). "Homeodomain transcription factor Phox2a, via cyclic AMP-mediated activation, induces p27Kip1 transcription, coordinating neural progenitor cell cycle exit and differentiation".PMID 16982676
  49. Ping Zhang et al. (2006). "Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line".PMID 16978399
  50. Lanying Song et al. (2007). "Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts".PMID 16959237
  51. Laurence Bockstaele et al. (2006). "Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"".PMID 16782892
  52. C Juhlin et al. (2006). "Loss of parafibromin expression in a subset of parathyroid adenomas".PMID 16728578
  53. Hui Wang et al. (2006). "Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer".PMID 16608517
  54. Mariko Tomita et al. (2006). "Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells".PMID 16603085
  55. Dan Lu et al. (2006). "Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis".PMID 16469745
  56. Shravanti Rampalli et al. (2005). "Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex".PMID 16166625
  57. Charles E Ducker et al. (2005). "Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis".PMID 16123142
  58. Anja Duursma et al. (2005). "p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation".PMID 16055707
  59. Cheng Zhang et al. (2005). "PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex".PMID 16055704
  60. Nikos Tapinos et al. (2005). "Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli".PMID 15967991
  61. Raju R Raval et al. (2005). "Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma".PMID 15964822
  62. Thorsten Maretzky et al. (2005). "ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation".PMID 15958533
  63. Pankaj Goyal et al. (2005). "Inhibition of nuclear import of LIMK2 in endothelial cells by protein kinase C-dependent phosphorylation at Ser-283".PMID 15923181
  64. Nichole Boyer Arnold et al. (2005). "Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein".PMID 15811853
  65. Malika Hamdane et al. (2005). "p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death".PMID 15741232
  66. Hong Bing Ma et al. (2005). "Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma".PMID 15655836
  67. Andrea G Lania et al. (2004). "Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein".PMID 15604292
  68. Ramesh Sreeramaneni et al. (2005). "Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor".PMID 15601844
  69. Hiroko Furumoto et al. (2005). "An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis".PMID 15601836
  70. Eun Joo Kim et al. (2005). "IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells".PMID 15572361
  71. Bing Zhu et al. (2005). "Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells".PMID 15526282
  72. Ian Pitha-Rowe et al. (2004). "Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention".PMID 15520223
  73. Daniel G Rosen et al. (2004). "Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival".PMID 15475444
  74. Vidya Mamidipudi et al. (2004). "RACK1 regulates G1/S progression by suppressing Src kinase activity".PMID 15254245
  75. Lea Madi et al. (2004). "The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition".PMID 15240539
  76. Takashi Suzuki et al. (2004). "Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor".PMID 15231680
  77. Chitkala Satyanarayana et al. (2004). "DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells".PMID 15207007
  78. Sung Kwon Moon et al. (2004). "Disialoganglioside (GD3) synthase gene expression suppresses vascular smooth muscle cell responses via the inhibition of ERK1/2 phosphorylation, cell cycle progression, and matrix metalloproteinase-9 expression".PMID 15175338
  79. Christina R Kahl et al. (2004). "Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I".PMID 14754892
  80. Tamar Golan et al. (2004). "The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade".PMID 14747478
  81. Roberto R Rosato et al. (2003). "Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells".PMID 14707268
  82. N J Trudgill et al. (2003). "Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction".PMID 14645692
  83. Seetharaman Balasenthil et al. (2004). "p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells".PMID 14530270
  84. Lin Wang et al. (2003). "Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer".PMID 14506155
  85. Tsieh Sun et al. (2003). "Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma".PMID 12949897
  86. Soichi Tsutsumi et al. (2003). "Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling".PMID 12783864
  87. Yu Long Hu et al. (2003). "Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells".PMID 12759391
  88. Marco Chilosi et al. (2003). "Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis".PMID 12707032
  89. Hesham M Amin et al. (2003). "Characterization of 4 mantle cell lymphoma cell lines".PMID 12683869
  90. Chris Albanese et al. (2003). "IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf".PMID 12589056
  91. Xianmin Xia et al. (2003). "The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest".PMID 12588990
  92. Heidi L Kenerson et al. (2002). "Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors".PMID 12384518
  93. Cristina Broceño et al. (2002). "RB activation defect in tumor cell lines".PMID 12379745
  94. Irene H L Hamelers et al. (2002). "Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells".PMID 12364325
  95. Katsu Ishigaki et al. (2002). "Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer".PMID 12107263
  96. Mihail S Iordanov et al. (2002). "The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor".PMID 12101233
  97. Luis M Schang et al. (2002). "Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4".PMID 12097586
  98. Yali Zhai et al. (2002). "Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas".PMID 11943708
  99. Sandra Ciarallo et al. (2002). "Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest".PMID 11940657
  100. Avi Shvarts et al. (2002). "A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling".PMID 11914273
  101. Kevin A Walter et al. (2002). "Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription".PMID 11909963
  102. R G Hardy et al. (2002). "Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon".PMID 11889072
  103. Cynthia C Sprenger et al. (2002). "Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis".PMID 11791184
  104. Zhongfa Yan et al. (2002). "Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1".PMID 11784716
  105. Russell D Klein et al. (2002). "Black tea polyphenols inhibit IGF-I-induced signaling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells".PMID 11756245
  106. Andrew J Skildum et al. (2002). "The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells".PMID 11741909
  107. Tadashi Yoshii et al. (2002). "Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest".PMID 11724777
  108. M S Neshat et al. (2001). "Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR".PMID 11504908
  109. K Kurose et al. (2001). "Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas".PMID 11395387
  110. B A Schmidt et al. (2001). "Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors".PMID 11358847
  111. A Schulze et al. (2001). "Analysis of the transcriptional program induced by Raf in epithelial cells".PMID 11316792
  112. Y Takasaki et al. (2001). "Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation".PMID 11254741
  113. R A Campbell et al. (2001). "Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance".PMID 11139588